Recent studies indicate that the primary T cell found in the nervous system in patients with MS is the CD8+ T cell, as patient-derived effector CD4+ T cells are difficult to effectively discern from regulatory T cells (Tregs), which reduce the response of effector T cells and prevent autoimmune disease (Kaskow & Baecher-Allan, 2018). Here, CD8A is linked to myeloid sarcoma.